Welcome to Malaysia Association for Cell Therapy  

D7-3-1 Block D7, Pusat Perdagangan Dana 1,
Jalan PJU 1A/46, PJU 1A, 47301 Petaling Jaya,
Selangor Darul Ehsan

Cell and Gene Therapy Products:
Research to Product Registration

Regenerative Medicine is an emerging field aimed to restore both structure and function to the musculoskeletal system. This field has great potential to transform the current practices and standard-of-care in Medicine. It integrates a multidisciplinary approach to address patient needs. To ensure that regulated advanced therapies are provided at clinical point-of-care (POC), adherence to current regulations and legislations need to be emphasized in tandem with the research and development of regenerative medicine products. In our local regenerative medicine landscape, the National Pharmaceutical Regulatory Agency (NPRA) in Malaysia ensures the quality and safety of pharmaceutical products, including Cell and Gene Therapy Products (CGTPs). The Regenerative Medicine Virtual Symposium 2021 with the theme of ?Cell and Gene Therapy Products: Research to Product Registration?, aims to provide a platform for the various stakeholders in the regenerative medicine industry to share their experience in meeting the requirements by the international regulators (i.e. Food and Drug Administration (FDA)) and local regulators i.e. NPRA and Medical Device Authority (MDA), to register their CGTPs as practical products for patient use. This symposium aims to gather all stakeholders including industries, researchers and regulators to exchange their views in this challenging transition time. This meeting also serves as a platform for your researchers, including postgraduate students and postdoctoral research fellows to present their research work related to regenerative medicine.

13 November 2021
8.00 am - 5.00 pm
Free Registration


Important Dates

Abstract Submission Deadline: 15 Oct 2021
Abstract Acceptance Announcement: 20 Oct 2021
Oral and e-Poster Video Presentation Submission Deadline: 5 Nov 2021
Deadline for Online Registration 11 November 2021
Virtual Symposium Date: 13 Nov 2021

Awards & Prizes

Best Oral/e-Poster presentation on awards
Submit your abstract now to stand a chance to win the best Oral/ePoster presentation awards.



0800 - 0815 Delegates/Speakers/Presenters Log-in to Zoom
0815 - 0900 Opening Ceremony
Session 1
Session Chair: Dr Lim Teck Onn / Dr Caroline Jee
0900 - 0930 Registration of Cell and Gene Therapy Products (CGTPs) in Malaysia Keynote speaker: Dr Evelyn Loh Yun Xi
Senior Principal Assistant Director, Biologics Section,
Centre for Product and Cosmetic Evaluation,
National Pharmaceutical Regulatory Agency,
Ministry of Health, Malaysia.
0930 - 0950 Commercialization journey of an allogenic cord blood-derived MSC product CARTISTEM for Knee OA in Korea, US, Japan and Malaysia Guest speaker: Dr Antonio Lee
CEO & Managing Director, MEDIPOST America Inc.; Rockville MD, USA
0950 - 1010 Oral Presentation 1-
Expedited Regulatory Pathways for Cell-based Therapy in Malaysia: The Way Forward
Dr Firdaus M Aziz
Oral Presentation 1
1010 - 1025 Break
Session 2
Session Chair: Dr Caroline Jee
1025 - 1055 GLP Toxicity Test for compliance with MDA Keynote speaker: Dr Samsulida Binti Abd. Rahman
1055 - 1115 The Malaysian Bioeconomy Ecosystem Guest speaker: Mr. Ahmad Fazil Ellias ,
Assistant Vice President, Industry Development Division, Healthcare , Malaysian Bioeconomy Development Corporation Sdn Bhd
1115 - 1135 Mending Broken Hearts : The Promise of Induced Pluripotent Stem Cells Guest speaker: Assoc. Prof. Dr. Tan Jun Jie
Advanced Medical and Dental Institute, Universiti Sains Malaysia
1135 - 1215 Oral Presentation 2-
Concept Paper: Composition and Action of Inflammatory Cells that Infiltrate the Synovium in Osteoarthritis,
Ms Ti Jia Wei

Oral Presentation 3-
3D composite Poly (lactic-co-glycolic acid)-Nano calcium sulfate-Fucoidan (PLGA-Ncs-Fu) induced differentiation of Human Bone Marrow stromal cells for tissue engineering application,
Ms Norshazliza Ab Ghani
Oral Presentation 2 - 3
1215 - 1235 Sponsored Talk Sponsor: BD Sdn Bhd
1235 -1345 Lunch Break
Session 3
Session Chair: Dato Dr Jai Mohan / Dr Caroline Jee
1345 - 1405 Musculoskeletal Regeneration with Autologous Peripheral Blood Stem Cells - Clinical applications and challenges Guest speaker: Dr. Saw Khay Yong
KLSMC, Malaysia
1405 - 1515 Oral Presentation 4-
The Effect of MSC Exosomes On Insulin Resistant Tenocytes
Mr Omar Maged

Oral Presentation 5-
Effects of Early Passaging on Biological Characteristics and Immunomodulatory Properties of Wharton?s Jelly Mesenchymal Stem Cells,
Ms Tan Li Jin

Oral Presentation 6-
A Systematic Review: Preclinical Findings to The Clinical Applications of the current Gene Therapies for Osteoarthritis,
Ms Atiqah Ab Aziz

Oral Presentation 7-
Evaluation of wound healing stimulatory effects of recombinant human fibroblast growth factor 2 on third-degree burned mouse model,
Mr Khanh-Thien Le

Oral Presentation 8-
A systematic review on exosomal piRNA abundance in blood circulation in human diseases,
Ms Goh Tuan Xin

Oral Presentation 9-
Cytokine expression on autoimmune disorder after Mesenchymal stem cells treatment,
Ms Lee Siew Ee

Oral Presentation 10-
Patient Outcomes Following Intra-articular Exosome Knee Injections: A Retrospective Review,
Dr Shankar Lognanathan
Oral Presentation 4 - 10
1515 - 1530 Break
Session 4
Session Chair: Dr Lim Teck Onn / Mr James Then
1530 - 1615 Opportunities and Challenges in Regenerative Medicine Industry During the COVID-19 Pandemic : Exploring Collaborative Potentials Between Malaysia and Taiwan Business Dialogue

from MACT Malaysia
  1. Dr Lim Teck Onn (President of MACT)
  2. Mr James Then, Director, Cryocord (Vice President of MACT)
  3. Mr Peter Choo, Director , CytoMed Therapeutics (MACT Member)
  4. Mr Wijenthiran Kunasekaran, Co-founder, Cytonex Sdn Bhd (MACT Member)
  5. Dr Saw Khay Yong, KLSMC (MACT Member)

from Taiwan:
  1. Ms Chang, Yi-Wen, General Manager, Gene and Stem Cell Biochemical Corp
  2. Dr. Ooi Hean, Vice director of International Center, China Medical University Hospital (CMUH) , Taiwan
  3. Mr Hundred.Huang, Taiwan Medical Tourism Development Association Taipei office Director, GSBC-Gene & Stem cell Biomedical Company Sales Director
  4. Ms Meiling Chang , Commissioner, Taiwan Medtour Organization
  5. Mr Poa-Kai Feng, GSBC, Primary Consultant, Taiwan

from Korea:
  1. Dr Antonio Lee, CEO & Managing Director, MEDIPOST America Inc.; Rockville MD, USA
1615 - 1630 Closing Ceremony
1630 - 1645 Winner Announcement for the Best Oral Presenters
End of Symposium


Member Email :

Password :

Image Verification :  
  Change image

Forgot Password?